Altimmune, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Altimmune, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Altimmune, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.08M, a 13.6% increase year-over-year.
  • Altimmune, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $13.5M, a 11.7% increase year-over-year.
  • Altimmune, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 31.3% increase from 2022.
  • Altimmune, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.1M, a 46.8% increase from 2021.
  • Altimmune, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.52M, a 114% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.5M $3.08M +$368K +13.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $13.1M $4.31M +$1.53M +54.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11.6M $3.65M +$975K +36.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.6M $2.47M -$1.45M -37.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $12.1M $2.71M +$582K +27.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $11.5M $2.79M +$738K +36% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $10.8M $2.68M +$2.67M +131479% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $8.1M $3.92M +$1.39M +54.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $6.71M $2.13M +$631K +42.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $6.08M $2.05M +$563K +37.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $5.52M $2.03K +$815 +66.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5.52M $2.54M +$1.83M +257% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $3.69M $1.5M +$177K +13.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.52M $1.49M +$1.15M +349% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.36M $1.22K -$214K -99.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.58M $710K +$432K +155% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $2.14M $1.32M +$1.03M +359% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.11M $331K +$40.7K +14.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $1.07M $215K -$193K -47.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.26M $279K +$210K +305% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.05M $288K +$192K +201% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $862K $290K +$37.6K +14.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $824K $408K +$51K +14.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $773K $68.8K -$238K -77.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $1.01M $95.6K -$357K -78.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $1.37M $252K -$86.9K -25.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $1.46M $357K +$11.7K +3.38% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $1.44M $306K -$54.6K -15.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $1.5M $453K +$258K +132% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $1.24M $339K +$112K +49.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.13M $345K +$163K +89.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $965K $361K +$175K +94.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $790K $195K +$101K +108% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $689K $227K +$93.8K +70.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $595K $182K -$17.7K -8.87% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $613K $186K -$297K -61.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 $910K $93.8K -$187K -66.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $1.1M $134K -$230K -63.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $1.33M $200K -$329K -62.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $1.66M $483K +$77.5K +19.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $1.58M $281K -$24K -7.86% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.6M $363K +$39.1K +12.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $1.56M $529K +$200K +61% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $1.36M $405K +$11.3K +2.86% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $1.35M $305K -$135K -30.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $1.49M $324K -$188K -36.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $1.67M $329K -$220K -40.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $1.89M $394K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-11
Q3 2012 $439K -$187K -29.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $512K -$32.7K -6% Mar 31, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $549K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q3 2011 $626K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $545K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.